Showing results (91-100 of 335) with videos related to
Sort By:
Pageof 34
Journal of Controlled Release : Official Journal of the Controlled Release Society|September 18, 2007
Intravascular drug release kinetics dictate arterial drug deposition, retention, and distributionBrinda Balakrishnan, John F Dooley, Gregory Kopia, et al.Nanotheranostics|February 28, 2022
Molecular Immune Targeted Imaging of Tumor MicroenvironmentTaha Rakhshandehroo, Bryan Ronain Smith, Hannah J Glockner, et al.Hypertension (Dallas, Tex. : 1979)|September 28, 2023
Nanoparticle-Based Therapies in HypertensionDarren Story, Alireza Aminoroaya, Zak Skelton, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|January 29, 2011
Primary monocytes regulate endothelial cell survival through secretion of angiopoietin-1 and activation of endothelial Tie2Shai Y Schubert, Alejandro Benarroch, Juan Monter-Solans, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|July 20, 2016
Drug deposition in coronary arteries with overlapping drug-eluting stentsFarhad Rikhtegar, Elazer R Edelman, Ufuk Olgac, et al.Proceedings of the National Academy of Sciences of the United States of America|June 16, 2004
Specific binding to intracellular proteins determines arterial transport properties for rapamycin and paclitaxelAndrew D Levin, Neda Vukmirovic, Chao-Wei Hwang, et al.Current Pharmaceutical Design|February 27, 2013
Importance of receptor-targeted systems in the battle against atherosclerosisElisabet Rosas, Igor Sobenin, Alexander Orekhov, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|May 31, 2012
Stent elution rate determines drug deposition and receptor-mediated effectsAbraham R Tzafriri, Adam Groothuis, G Sylvester Price, et al.Journal of Controlled Release : Official Journal of the Controlled Release Society|November 18, 2005
Local and systemic drug competition in drug-eluting stent tissue deposition propertiesAndrew D Levin, Michael Jonas, Chao-Wei Hwang, et al.Pageof 34